Meta-analysis of 7 studies (802 patients) with de novo metastatic nasopharyngeal carcinoma: adding local consolidative radiotherapy to immunochemotherapy improved PFS (HR 0.48) but showed no significant OS benefit (HR 0.52, 95% CI 0.18-1.61).
Meta-analysisn = 802
Ma et al. Local Consolidative Radiotherapy Combined With Immunochemotherapy for De Novo Metastatic Nasopharyngeal Carcinoma: A Meta-Analysis